Berson, Yalow, Sorrentino and Roswit (1) designed a simplified technic for estimating the rate at which the thyroid gland clears the plasma of intravenously administered radioiodide (I'3s). The amount of I18' taken up by the thyroid in 30 minutes is correlated with the average concentration of I131 in the plasma during the half hour. Plasma I131 is not actually measured, but is determined on the assumption that its concentration is a function of the weight of the body. Regardless of this and other assumptions involved, the method is one of the most precise in evaluation of thyroidal function in our experience (2, 3) .
Calculation of clearances at periods of time less than 30 minutes has been found necessary on those infrequent occasions when there was an electronic or mechanical failure of the radiation detector, or when the patient was so restless that the uptake tracing became erratic before the 30 minute time was concluded.
In an attempt to determine whether the Berson procedure might be shortened, 1 
METHOD
The Berson technic (1) was followed closely, with the only modification consisting of adaptation to our in vivo equipment: a 2 inch (5.1 cm) sodium iodide (thallium-activated) scintillation crystal situated at a distance of 20 cm between the surface of the crystal and the skin overlying the thyroid. The radioactivity was registered continuously on a counting rate-meter and in turn on an Esterline-Angus recorder (for example, Figure 1 ). Pulse-height discrimination was so set that 100 counts per second were recorded per microcurie of I" in the neck.
The Details on the patient with "iodide goiter" have been reported (4). Paris and associates, studying this patient and other patients with "iodide goiter," found that after a rapid initial uptake of I131 by the goitrous thyroid, there was a reversal of the uptake curve (4) . The rate of disappearance of I131 from the thyroid gland exactly matched the rate of disappearance of I131 from the blood stream. Since no hormonal J131 was recoverable, it would appear that these patients had an adequate or exaggerated iodide-trapping mechanism, but an inability to bind any of the halide to protein. In consequence, an equilibrium between thyroidal iodide and plasma iodide was reached and maintained. Such an equilibrium presumably occurs even when the binding rate of the thyroid is normal (5) . Subsequently, the patient was taken off iodide drugs and a fully normal Gardner, Hayles, Woolner and Owen (9) , in a study of goitrous cretins, found that those patients incapable of converting thyroidal iodine to the protein-bound form were characterized by a reversing uptake curve. The release rate from the thyroid and the renal excretion rate of J131 were the same. Our patient with goitrous cretinism would seem to fit into this category.
By analogy with the various types of patients described above (goitrous, cretins, iodide goiter, propylthiouracil goiter), the same defect characterized the patient (Table II) who had had I131 therapy for hyperthyroidism, the four patients with Hashimoto's disease and the one with an undiagnosed goiter. From Ingbar's data it is difficult to explain the findings in Hashimoto's disease; he estimated that the thyroidal binding rate had to be inhibited 90 per cent to obtain a "negative slope accumulation curve" (7) . The level of hormonal iodine, i.e., butanol-extractable iodine and butanol-insoluble iodine (10) in the plasma of these patients often totals a normal value for protein-bound iodine (for example, Patients 2 and 4), suggesting a binding rate considerably greater than 10 per cent of normal. Although our experience with the Berson test in Hashimoto's disease is limited to these four patients, the unanimity of the finding of a reversing uptake curve suggests a new diagnostic clue.
The eleventh patient is difficult to classify, because we are not certain what type of goiter she had. She was 47 years old, with mitral stenosis and insufficiency, and was found to have a small, diffuse, non-nodular goiter. She was euthyroid clinically. The basal metabolic rate was plus 18 per cent. The protein-bound iodine was increased (8.7 sAg per 100 ml) but the uptake of I131 (TABLE II) . Uptake is recorded in microcuries of I131. The abscissa is time in minutes after equilibration of the 131 in the neck, that is, before actual thyroidal uptake has begun. The test was performed twice on Patient 1: la, before giving thyroid-stimulating hormone, and lb, 24 hours after intramuscular injection of 10 units of bovine thyroid-stimulating hor- With short-time constants available, the Berson clearance test may be abbreviated as needed for the convenience of the patient, or as required if the equipment should fail before the standard test is concluded, or as needed for evaluation of the rare patient who traps 1131 but releases it promptly, presumably still in its inorganic form.
Eleven patients, from among 1,250 studied, exhibited the phenomenon of normal or accelerated thyroidal uptake of J131 followed, within the half hour of the Berson test, by reversal of the uptake curve. One patient was a goitrous cretin, one -had an iodide goiter, three were receiving propylthiouracil or methimazole (Tapazole), and one had been treated with a therapeutic dose of I113. In these six patients, apparently complete block in thyroidal protein-binding of iodine existed; the loss of thyroidal radioiodide reflected the equilibrium between thyroidal and plasma iodide, an equilibrium dominated by the renal excretion of iodide.
The remaining five patients, four with Hashimoto's disease and one with a goiter of undiagnosed type, also exhibited a reversal of I13" uptake during the Berson test. Here the explanation is less clear; serum values for protein-bound iodine do not warrant the assumption of a prominent defect of protein-binding of iodine in the thyroid.
